Chronic or episodic severe itch is recurrent in atopic dermatitis (AD). Nonhistaminergic itch pathways are suggested to dominate in AD itch, contributing to an "itch-scratch-itch cycle" that prolongs and worsens itch, pain, and skin lesions. We hypothesized that nonhistaminergic neuronal sensitization contributes to itch in AD. Hence, we compared sensitivity with thermal, mechanical, and chemical pruritic stimuli in patients with AD and controls. The study comprised 25 patients with AD with chronic itch and 25 healthy controls. Questionnaires on itch characteristics were administered, and sensory tests were conducted intralesionally, extralesionally, and in homologous areas of controls. Thermal and mechanical quantitative sensory testing (QST) as well as histamine and cowhage provocations were performed. Subsequently, hyperknesis and vasomotor reactivity were assessed. Average itch and associated pain among patients with AD were 60.7 6 4.3 and 39.7 6 5.2 (VAS 0-100 ), respectively. Patients experienced significantly higher itch from cowhage both intralesionally and extralesionally compared with controls, whereas histamine-evoked itch intensity was not significantly different between groups. No group differences were found for thermal quantitative sensory testings or pain evoked by itch provocations. Patients had decreased mechanical detection thresholds intralesionally and increased mechanical pain sensitivity intralesionally and extralesionally. Lastly, patients exhibited intralesional and extralesional hyperknesis before chemical itch provocations and augmented hyperknesis after itch provocations. Increased itch in response to cowhage (but not histamine) suggests nonhistaminergic pathway-specific itch sensitization in AD, whereas increased susceptibility to mechanically evoked itch and pain, particularly intralesionally suggests sensitization of mechanosensitive circuitry not normally associated with itch. Drugs targeting the nonhistaminergic (PAR2/TRPA1 1 ) itch pathway and itch sensitization are promising for treating AD itch.
Introduction
Atopic dermatitis is a chronic pruritic inflammatory skin condition characterized by lesions with erythema, exudation, excoriations, lichenification, and xerosis as well as chronic or episodic itch and cutaneous pain. 18, 25, 33, 86, 90 The disease is common, can be debilitating for affected patients, and is often difficult to treat adequately. 68, 90 Pathoetiologically, atopic dermatitis (AD) is associated with genetic, immunological, environmental, and skin barrier factors. 32, 86 Recently, neuronal sensitization has also been proposed as a disease contributor. 41, 87, 97 Knowledge on the neurophysiological basis of itch has been greatly expanded in the last decade as parallel peripheral pathways of itch transduction have been discovered and explored. 6, 45, 60, 84 In humans, the 2 most wellstudied pathways of itch rely on mechanoinsensitive C-fibers (CMi) transmitting for instance histaminergic itch and polymodal C-fibers (PmC) transmitting nonhistaminergic itch. 36, 45, 60 To a certain extent, these fibers express different molecular transducers important for itch signaling; eg, CMi fibers express histamine receptor 1 and PmC fibers express proteinase-activated receptor-2 (PAR2), which tryptase and mucunain activate to induce itch. 31, 39 It is well established that after acute pain as well as in chronic inflammatory and neuropathic pain conditions, peripheral nociceptors may exhibit increased sensitivity to various stimuli. At the same time, the spinal nociceptive processing of afferent input can be facilitated or disinhibited. 15, 53, 56, 77 These processes are proposed to contribute to the aggravation and chronification of pain in patients and mediate clinical phenomenona such as hyperalgesia and allodynia to mechanical and thermal stimuli. 77, 94 It is currently unknown whether similar processes contribute to increasing itch severity in patients suffering from chronic inflammatory itch conditions, such as AD. The indirect evidence of neuronal sensitization in AD includes: (1) sustained itch after resolution of active lesions, 17 (2) itch in response to normally innocuous mechanical stimuli (such as certain fabrics), 40, 92 (3) poor correlation between objective disease severity (eg, SCORAD) and itch intensity, 23 (4) case-based indications of an antipruritic effect of centrally acting antihyperalgesic drugs, 71 and (5) altered expression of molecular transducers on peptidergic cutaneous fibers. 83 Sensitization to histamine-induced itch and skin reactivity in AD have been studied extensively. 68, 83, 91, 92 Generally, itch in response to histamine provocation is unchanged or even Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.
decreased in nonlesional AD skin vs healthy skin, and inconsistent results have been derived from intralesional histamine provocations. 5, 38, [41] [42] [43] 48, 67, 91 This is consistent with the fact that antihistamine treatment has little or no effect on clinical itch severity in AD and thus histaminergic signaling is considered to have little implication on the pathophysiology. 68, 90, 93 Recently, a nonhistaminergic human model of itch, relying on the naturally occurring PAR2 agonist, mucunain from the cowhage plant, has been reintroduced. This type of evoked itch is entirely resistant to antihistamines 45, 60 and evokes mild nociceptive sensations akin to those associated with itch in AD. 52, 79 Accordingly, it has been suggested that this model may much more accurately mimic itch in AD and other conditions than the rigorously studied histaminergic models of itch. 34, 59, 67 The aim of this study was to compare sensory sensitivity to pruritic chemical, thermal, and mechanical stimuli between patients with AD with chronic itch and healthy controls (HCs), investigating both lesional and nonlesional skin areas.
Methods

Participants
Study subjects comprised 25 patients with AD (25.2 6 0.9 years, 10M/15F) and 25 healthy age-and sex-matched volunteers (26.3 6 1.3 years 14M/11F). All patients with AD fulfilled the diagnostic criteria of the UK Working Party and were initially diagnosed by a dermatologist. Patients were only included if they had chronically (.6 weeks 82 ) itching AD with mean daily itch rated above 3 ([numerical rating scale] NRS 0-10 ), lesions manifesting on the upper extremities, and an eczema-free skin area also on the upper extremities. Use of antihistamines was discontinued 48 hours before the experiment and all topical agents and emollients were discontinued 24 hours before the experiment. To enable the study of neuronal sensitization in patients with chronically itchy, treatmentresistant AD in situ, patients were instructed to continue their usual treatment regimen uninterrupted, with the exceptions stated above. Before enrollment, all participants were explicitly informed, verbally and in writing, that they were free to withdraw from the study at any time and that any procedure they deemed intolerable would be ceased immediately.
Study procedure
All subjects provided written informed consent before experimental procedures, and the regional ethics committee approved the study (N-20150058) . Figure 1 provides an overview of the conducted experimental procedures. Before the experimental session, patients with AD were evaluated using Scoring Atopic Dermatitis (SCORAD) 1, 46 and completed a Danish version of the Eppendorfer Itch Questionnaire 23 as well as the adapted Danish Itch Severity Scale questionnaire 99 (initially developed by Yosipovitch et al. 98 deriving descriptors from the McGill Pain Questionnaire). Thereafter, two 4 3 4 cm square areas were Figure 1 . Flow chart of experimental protocol. A total of 4 itch provocations were conducted (2 in lesional and 2 in nonlesional skin) in a randomized order, with provocations always alternating between the 2 areas. The order presented in the picture represents an example (greyed out provocations not conducted). The entire experimental session lasted for approximately 3 hours. AD, atopic dermatitis; CDT, cold detection threshold; CPT, cold pain threshold; eVAS, electronic visual analog scale; FLPI, full-field laser perfusion imaging; MDT, mechanical detection threshold; MPT, mechanical pain threshold; MPS, mechanical pain sensitivity; NRS, numerical rating scale; HPT, heat pain threshold; WDT, warmth detection threshold; WUR, wind-up ratio. marked on the upper extremities: 1 in a representative atopic lesion and 1 in an area of eczema-free skin. Scabbed and significantly exudative or lichenificated lesions were avoided; if not possible, an area in the margin of such lesions was used. The anatomical locations of these areas were mirrored in the HC group. All experimental procedures were subsequently conducted within these 2 areas (with the order of lesional vs nonlesional being randomized) following the sequence outlined in Figure 1 . For all outcomes, comparisons were made between lesional/nonlesional sites in AD and to anatomically corresponding control areas in HCs. All sessions were conducted in the same temperature-controlled laboratory at ;21 to 22˚C. Patients with AD and HCs were enrolled and tested in parallel to avoid potential seasonal biases. 55 
Quantitative sensory testing
The applied quantitative sensory testing (QST) protocol was partly derived from the guidelines of the German Research Network on Neuropathic Pain (DFNS). 73 The verbal instructions (in Danish) for participants from the DFNS protocol were derived from the supplementary materials of Olsen et al. 65 
Thermal detection and pain thresholds
Tests for cold detection threshold (CDT), warmth detection threshold (WDT), cold pain threshold (CPT), and heat pain threshold (HPT) were performed using a Medoc Pathway (Medoc Ltd, Ramat Yishay, Israel) equipped with a 3 3 3 cm advanced thermal stimulator probe with a baseline temperature of 32˚C. Ramping stimuli of 1˚C/seconds were delivered until the subjects identified the associated threshold (first perception of cold or warmth and first perception of cold-or heat-induced pain) by pressing a button. Thereafter, the temperature of the probe returned to the baseline temperature at a rate of 5˚C/seconds. The results were calculated as the arithmetic mean of the thresholds from 3 repeated ramps.
Mechanical detection, pain threshold, and sensitivity
To determine the mechanical detection threshold (MDT), a set of 20 calibrated von Frey filaments (North Coast Medical, Gilroy, CA) with exerted forces ranging from 0.078 mN to 2.9 N was applied over 5 ascending/descending series of stimuli. The subjects were asked to report upon any sensation from the area (usually very light touch). The final MDT was calculated as the mean of the values obtained in each of the 5 series of stimuli. The mechanical pain threshold (MPT) was evaluated using a set of 7 weight-calibrated pinprick stimulators (MRC Systems, Heidelberg, Germany) with weights from 8 to 512 mN (Log2 scale). During 5 ascending/descending series of stimuli, the subjects reported when a perception of "sharpness" or "pricking pain" was first sensed. The final MPT was calculated as the mean of the values obtained in the 5 series of stimuli. The mechanical pain sensitivity (MPS) was assessed to detect pinprick hyperalgesia to suprathreshold stimulation. The 7 pinprick stimuli were applied in ascending order, and the subject was instructed to rate pain intensity of each stimulus on a numerical rating scale (NRS 0-10 , 0 5 no pain, 10 5 worst imaginable pain) allowing the use of decimals. The final MPS was calculated as the arithmetic mean of 2 consecutive series. Wind-up ratio was assessed using the pinprick stimulator 1 intensity above the individual average MPT. The subjects were asked to rate the pain intensity after a single stimulus and thereafter the last of a subsequent series of 10 consecutive stimuli (1 stimulus/second). This procedure was repeated twice, and a mean ratio was calculated.
Chemically provoked itch
Itch induction
Two types of itch provocations were conducted. Histaminergic itch was evoked using intraepidermal punctures of 1% histamine dihydrochloride with standard 1-mm skin prick test (SPT) lancets (Allergopharma, Hamburg, Germany). A drop of histamine solution was placed in the predetermined area and an SPT lancet was pricked through the histamine into the epidermis using a 120-g weight-calibrated device (Aalborg University, Aalborg, Denmark) for 1 to 2 seconds. 9, 13 Nonhistaminergic itch was induced using cowhage spicules, which contain the PAR2 agonist mucunain. The spicules were prepared immediately before administration under a stereomicroscope (Seben Incognita microscope; Seben GmbH, Berlin, Germany) using a negative grip tweezer (Electron Microscopy Science, Dumont, Switzerland). Approximately 45 spicules were applied to the skin and gently rubbed into the skin for 15 to 20 seconds to ensure insertion (the delivered volume of mucunain using this method has been calculated to 15-30 ng) . 67 Histamine solution and cowhage spicules were stored at 4˚C between sessions but always taken out well in advance of experiments and applied when at room temperature. Both of these human surrogate models of itch have previously been used and found to be reliable. 6,13
Assessment of evoked itch and pain
Intensity of itch and pain was assessed using 2 visual analogue scales (VAS), 1 for each sensory quality, after each itch provocation. Two computerized 100-mm VASs ranging from 0 to 100 (eVAS Software; Aalborg University) installed on a Samsung Note 10.1 Tablet (Samsung, Seoul, South Korea) were used. The subjects were instructed to report the occurrence and intensity of the aforementioned sensations continuously throughout the 6-minute, 0.2 Hz sampling period. On the VASs, 0 indicated "no itch"/"no pain" and 100 indicated "worst imaginable itch"/"worst imaginable pain." The subjects were instructed that itch and pain might, or might not, occur after any of the administered provocations and instructed only to rate itching/ painful sensations and not innocuous associated sensations such as tingling or warmth. They were also instructed to disregard the mild initial pricking pain associated with insertion of spicules and the SPT puncture. From the VAS/time data, temporal itch and pain-intensity profiles were generated, and mean as well as individual peak itch/pain intensity were calculated.
Assessment of hyperknesis at baseline and after itch provocations
Cutaneous mechanical stimuli delivered by a needle or a thin filament typically induce a pricking sensation occasionally followed by mild itch both in HCs and to a greater extend in patients with chronic itch. 20, 40 After an experimental itch provocation, the surrounding skin area becomes increasingly itchy in response to this type of mechanical probing. 52, 78, 80 In the present study, sensitivity to mechanically evoked itch was tested before and ;12 minutes after each itch provocations with 3 von Frey filaments; (9.8, 13.7, and 19.6 mN; North Coast Medical, Gilroy, CA) by stimulating with each filament 2 3 3 times, for 2 to 3 seconds, each time instructing the subject to report the resulting itch intensity on a numerical rating scale (NRS 0-10 , with same outer labels as the previously described VAS). The von Frey stimuli were delivered immediately next to the sites of itch provocation (0.5-2 cm distance) within the predefined 4 3 4 cm areas, but never directly within wheal reactions or the area of spicules insertion.
This technique and the choice of von Frey filaments have previously been described in detail. 7 Subjects were instructed before the onset of data collection that: (1) itch is defined by inducing a desire to scratch the probed area and hence this should be the hallmark of their rating, (2) itch may or may not occur in response to the stimuli, and (3) itch could occur during the stimulus itself or immediately after. Nonuniform terminology is currently being used to describe itch-associated mechanical dysesthesias; alloknesis (itch in response to a normally nonitching stimuli) and hyperknesis (increased itch in response to a normal itch or pain-evoking stimuli). 7, 10, 30, 47, 49 Because the presently applied methodology is designed to induce mild itch in HC skin and elicits mild itch in the majority of HCs before any itch provocations, we apply the term mechanically evoked itch when referring to such data obtained in normal skin of HCs. Hyperknesis is used specifically when referring to any observed increase in mechanically evoked itch rating, probed as described above. This definition is in line with the originally proposed nomenclature.
49,50,80
Inflammation imaging and wheal measurements
Superficial blood perfusion was assessed at baseline and after the histamine provocation to measure the neurogenic inflammatory response. Cowhage produced very limited or no discernable flare. The measurements were taken using a MoorFLPI-1 (Moor Instruments Ltd, Axminster, United Kingdom) with a 35-cm distance between the camera and the skin, exposure time of 8.3 ms, and 160 units of gain. The full-field laser perfusion imaging (FLPI) data were analyzed using MoorFLPI Review V4.0 proprietary software. The induced increases in average and peak superficial blood perfusion within the 4 3 4 cm premarked areas were used as proxies for inflammation intensity. Moreover, the histamine-evoked flare area was calculated as the area of $30% perfusion rate compared with the surrounding background in accordance with previously described methodology. 7, 8, 65 Wheal was measured by the longest diagonal and the orthogonal diagonal approximately 15 minutes after the histamine pricks were conducted in accordance with standardized recommendation for SPT. 35 
Statistics
Statistical analyses were performed using SPSS (version 23; IBM Corporation, Armonk, NY) and GraphPad Prism (version 6.0; La Jolla, CA). Sample size estimations were based on previous studies and test-retest reliability data. The obtained data are presented as arithmetic mean 6 SEM, unless otherwise stated. Data were tested for normality using visual inspection and, if unclear, using the Shapiro-Wilk normality test. Peak and mean of itch/pain were extracted from temporal VAS recordings and compared between groups. The primary statistical analyses for all outcome measures, with the exception of hyperknesis, MPS, and FLPI (repeated parameters), were performed with independent samples t tests and corrected for multiplicity using the HolmSidak approach. For MPS, hyperknesis, and FLPI, repeated measures ANOVAs were constructed with the within-subject factors stimulus (MPS; 7 levels, 1 per stimulator) and time (hyperknesis and FLPI; 2 levels, before and after itch provocation) and the between-subject factor group (all 3 outcomes; AD vs controls). Mauchly test of sphericity was used, and in cases where sphericity was violated, the Greenhouse-Geisser correction was applied. An unplanned, explorative within-subjects analysis (paired t test) was conducted specifically for HPT as a difference was evident from the main between-subjects comparison. A P-value of # 0.05 was considered significant for all analyses.
Results
All subjects in both groups completed all study procedures without the occurrence of immediate or delayed adverse reactions or withdrawals. For all parameters, no or very modest, insignificant differences were observed between the 2 HC skin areas, showing limited combined differences associated with sensory topography between the investigated sites within the groups.
Severity and characteristics of itch and atopic dermatitis
The patients with AD reported a moderate-to-severe mean itch episode intensity (60.7 6 4.3 VAS 0-100 ) as well as mild-tomoderate pain (39.7 6 5.2, VAS 0-100 ) associated with their skin lesions. The itch characteristics, presented as medians and quartiles on a Likert Scale 0-4, were most consistently described as: "warm" 5 3 (3-4), "burning" 5 3, (3-4), "searing" 5 3 (2-4), and "stinging" 5 3 (1.25-4). The most prevalent perceived aggravating factor was "warmth" (3, (3) (4) , and "cold" was most consistently described as alleviatory 5 3 (3-4). The most frequent emotional descriptors were: "annoying" 5 4 (3.25-4), "bothersome" 5 4 (3-4), and "my only desire: no itch" 5 4 (3-4). Significant sleep interference from itch was reported 5 3 (3-4). The mean Itch Severity Scale score was 12.5 6 0.4 (0-21 scale), and the average SCORAD was 35.4 6 3.1 (0-103 scale). The most common lesional anatomical area was in and around the flexural area of the elbow. Qualitatively, most patients reported that they were under the impression that the cutaneous pain associated with their lesions was, mainly or entirely, a self-inflicted consequence of scratching.
Quantitative sensory testing
Thermal detection and pain thresholds
No significant differences or trends were observed with regard to any thermal detection or pain thresholds between the AD and control group in lesional or nonlesional skin areas ( Table 1 ). In the AD group, a within-subject analysis for HPT in lesional (41.2 6 0.8˚C) vs nonlesional skin (43.2 6 0.9˚C) demonstrated relative heat hyperalgesia intralesionally (P 5 0.009, uncorrected).
Mechanical detection, pain thresholds, and mechanical pain sensitivity
Intralesionally, the AD group exhibited significantly increased MDT compared with the control group, indicative of tactile hypoesthesia ( Table 1) . This difference was not present when comparing nonlesional skin of the AD group with the corresponding area in HCs. No significant differences were observed for MPT, but an insignificant trend toward decreased MPT in lesional skin of the AD group was observed ( Table 1) . No significant differences were observed for the wind-up ratio, known as a perceptual correlate of temporal pain summation. Sensitivity to suprathreshold mechanical pain pinprick stimuli was significantly increased in both lesional (P , 0.01, group main effect) and nonlesional skin (P , 0.05, group main effect) of the patients with AD ( Fig. 2A, B) . This result indicates mechanical hyperalgesia www.painjournalonline.commanifesting primarily to suprathreshold stimuli intensities both within and beyond the eczematous skin areas.
Itch provocations
Histamine-induced itch
Histamine-induced mean and peak itch intensities did not differ significantly between patients with AD and HCs, regardless of whether the provocations were performed in lesional or nonlesional skin (Fig. 3A, B) . However, a notable trend toward increased itch responses in lesional AD skin when compared with homologues HC skin was observed for both mean and peak itch intensities (both: P 5 0.07), and these differences were only rendered insignificant when correcting for multiple comparisons. The sensitivity to histamine-induced itch in nonlesional skin of patients with AD vs HCs was highly similar (P 5 0.74 for mean itch, and P 5 0.98 for peak itch). Histamine provocations induced mild pain in a few individuals, but mean peak pain intensity scores were never .10 (VAS 0-100 ), regardless of whether provocations were conducted intralesionally or extralesionally.
Cowhage-induced (nonhistaminergic) itch
Cowhage-evoked mean and peak itch intensities were significantly increased in lesional AD skin vs corresponding skin in HCs (both: P , 0.01), Fig. 3C , D. For instance, the mean itch in response to cowhage was 63% higher in the patients with AD (48.3 6 3.9, VAS 0-100 ) compared with the HCs (30.4 6 3.9, VAS 0-100 ). A similar finding was made when comparing nonlesional AD skin with the corresponding skin in HCs for the mean cowhage-evoked itch (P 5 0.03); however, here the peak itch intensity difference was not statistically significant (P 5 0.087).
Temporal itch-intensity profiles after cowhage provocations are shown in Figures 3C and 4D . Cowhage induced mild pain in a minority of subjects in lesional (peak scores: AD group, 15.1 6 4.3; HC group, 10.2 6 2.4), and nonlesional skin (peak scores: AD group, 12.3 6 2.5; HC group, 11.5 6 3.4), but no significant differences were present between groups.
Mechanically evoked itch and hyperknesis
Of the 300 von Frey triplicate stimulations delivered to the skin of HCs prior to any itch provocations 59.7% were rated as itching ($0.5 on NRS 0-10 ), whereas the equivalent percentage in AD was 73.3% (P , 0.001). Patients with AD also exhibited significantly more intense itch in response to von Frey stimuli in both lesional and nonlesional skin before itch provocations (AD group: 2.4 6 0.3, HC group: 0.9 6 0.1). After histamine and cowhage-induced itch provocations, both the AD and HC group developed significant hyperknesis; however, this facilitation was more pronounced in the AD group (Fig. 4A, B) . Patients with AD also displayed significant hyperknesis in lesional skin after cowhage Asterisks to the left of the stimulus response curves indicate a significant group main effect (scores of entire stimuli series), whereas asterisks immediately above data points indicate post hoc group differences (group 3 stimulus interaction) for ratings produced by each of the pinprick stimulators. AD, atopic dermatitis; HC, healthy control; NRS, numerical rating scale. Significance indicators: * 5 P # 0.05, ** 5 P # 0.01. Note that although histamine-induced itch was not significantly increased in lesional AD skin (A), tendencies for both peak and mean ratings were observed (P 5 0.07). Statistical results were based on mean scores for the 0 to 6 minutes period. AD, atopic dermatitis; HC, healthy control; VAS, visual analogue scale. * 5 P # 0.05, ** 5 P # 0.01. (Fig. 4B) ; however, here, the histamine provocation did not produce significantly more hyperknesis in patients with AD compared with HCs. In summary, patients with AD displayed hyperknesis at baseline, and after itch provocations (both histamine and cowhage intralesionally, and only cowhage extralesionally) the AD group developed more pronounced hyperknesis than the HCs.
Neurogenic inflammation and wheal reactions
No differences were observed for superficial blood perfusion in nonlesional areas at baseline. Patients with AD expectedly had increased blood perfusion levels in lesional skin compared with homologous control areas (P , 0.01), corresponding to the observed erythema. After histamine provocations, both HCs and patients with AD exhibited visually perceptible flare reactions immediately surrounding the SPT site. Analysis of the FLPI images showed that the flare reactions in nonlesional skin were more developed (higher peak intensities and larger areas) in HCs (both: P , 0.05), indicating that histamine-induced neurogenic flare is blunted in patients with AD. Perfusion assessments including the area quantification technique could not be reliably applied because of significant ceiling effects (presumably both physiological and technological) observed in the lesional skin of the patients with AD (Fig. 5 , column a-b, row [4] [5] [6] . No group differences were found in relation to wheal sizes when comparing lesional or nonlesional areas. However, 3 abnormally large wheals, .40 mm 2 and .5 SDs higher than average HC wheals, as well as 4 satellite wheal reactions (separately developed wheal reactions several centimeter away from histamine prick site) were observed only in the lesional skin of the patients with AD.
Discussion
This study demonstrates for the first time that patients with AD with chronic itch exhibit selective intralesional and extralesional hypersensitivity to cowhage provocations (nonhistaminergic itch). Moreover, patients with AD have exaggerated responses to pain-and itch-evoking mechanical stimuli both intralesionally as well as extralesionally, ie, pinprick hyperalgesia and hyperknesis, respectively, likely mediated by central sensitization processes.
Itch and pain in atopic dermatitis
The AD group reported moderate-to-severe chronic itch with a rated severity equivalent to previous studies. 23, 25, 64 Notably, 23 of 25 patients (92%) reported the presence of pain, and the average daily pain associated with the itch episodes was 39.7 6 5.2 (VAS 0-100 ). Although the frequency of cutaneous pain in AD has previously been investigated (Brenaut et al. 18 reported that ;87% of patients with AD experience associated pain and O'Neill et al. 64 reported a 57.3% prevalence of pain in AD), the intensity of the pain has, to our knowledge, not previously been assessed. It is unclear whether scratching chiefly drives the cutaneous pain or if it is also spontaneously occurring. Given that both histaminergic and nonhistaminergic models of itch generally produce mild spontaneous pain and hyperalgesia, it is likely that both of these mechanisms are involved. 10, 13, 36, 52, 79 The quality of itch in AD was generally reported as having a warm, pricking, searing quality and as being intensified by warmth as well as alleviated by cooling, all of which is well aligned with findings from previous studies. 23, 25, 64 While aggravation of itch by warmth is speculatively proposed to rely on TRPV1/4-mediated signaling either summating with pruriceptive activity at the primary afferent level or converging onto pruriceptive pathway spinal dorsal horn neurons, 3, 4 alleviation by cooling is likely predominantly mediated by spinal gating of pruriceptive signaling, arising from activity of TRPM8-positive cold-receptive Adfibers. 11, 19, 96 An alternative explanation, perhaps particularly relevant for warm-induced aggravation of itch, is that simple physical factors such as temperature-induced modulation of neuronal membrane potential, channel kinetics, or receptoragonist interactions cause thermally induced itch aggravation/ inhibition. 21, 22, 29 Lastly, although sweat has been proposed as a potential link between feeling warm and concurrent itch exacerbation, a recent study failed to show pruritogenic or itch-sensitizing properties of sweat in humans. 62 
Thermal sensory sensitivity is normal in AD
Standardized thermal QSTs yielded mean thresholds comparable to those found in the normative data set both when conducted intralesionally and extralesionally 65, 72, 73 ; however a paired analysis of HPT in lesional vs nonlesional AD skin did indicate mild heat hyperalgesia. One previous study found minor but significant impairments in warmth and cold detection thresholds in patients with AD, whereas a similar recent study failed to detect significant differences in thermal sensitivity. 69 Taken together with the present results, this indicates that alterations in thermal detection and pain sensation are likely not a prominent feature in AD as is the case, eg, for certain neuropathic 16, 56 and musculoskeletal pain etiologies. 28, 89 Notably, a previous study found that noxious suprathreshold heat stimuli evoke itch in AD, conceptually corresponding to heatinduced hyperknesis. 40 This type of sensory test is conceivably a more valuable assessment in patients with AD than standardized thermal QST.
Intralesional hypoesthesia in AD
The MDT was found to be increased intralesionally but not extralesionally within the AD group. The MDT is a perceptual correlate of Ab-mechanoreceptor function and as such signifies tactile sensitivity. 54, 72, 73 Two explanations to the reduced tactile sensitivity are most plausible: (1) prolonged scratching could cause cutaneous nerve fiber density decrease, perhaps affecting mechanosensitive units, 70 (2) the finding reflects an indirect effect of skin barrier alterations, ie, lichenification, excoriation, and scaling, reducing responses to light von Frey stimuli (although attempts were made not to directly stimulate scabbed or extensively excoriated, exudative, and lichenificated areas). In either event, evidence suggests that the loss of tactile sensitivity might have functional implications in AD. For example, a study found that the itch-alleviating effect of scratching is blunted in lesional skin of patients with AD compared with HCs, 42 and innocuous mechanical stimulation likely contributes to scratchmediated itch alleviation.
Intralesional and extralesional pinprick hyperalgesia in AD
The MPT was overall on par with previous studies in HCs. 65, 72 Although insignificant, a trend was observed toward reduced MPT in intralesional sites compared with homologous sites in HCs, indicative of mechanical hyperalgesia. More considerably, MPS increased, particularly in intralesional skin, but also to a lesser extent extralesionally, when comparing patients with AD with the HCs. The mechanism behind hyperalgesia to suprathrehsold pinprick also affecting nonlesional skin can only be speculatively accounted for. Three conceivable mechanisms are (1) peripheral sensitization of mechanosensitive primary afferents (Cand Ad-fibers), as indicated by increased responses to cowhage provocations. Evidence suggests that patients with AD have increased circulatory concentrations of several proinflammatory cytokines, chemokines, and neurotrophic factors, including, eg, CCL1, interleukin-2 and nerve growth factor (NGF). 37, 63, 85, 88 In humans, intradermal NGF has been experimentally shown to cause both prolonged mechanical hyperalgesia and increased itch sensitivity to cowhage in the absence of inflammation. 74, 75 Hence, increased systemic NGF-levels could explain these 2 findings cooccurring extralesionally in patients with AD in the present study. Lastly, prolonged serum changes in chemokines and cytokines concentration might lead to increased sensitivity of peripheral nerves. 24, 37, 58 For instance, CCL1 has been shown to sensitize nociceptors in mice, 2 CCL11 (also increased in the serum of patients with AD and correlated with disease severity) 44 is upregulated in rodent models of cutaneous hyperalgesia, 24 and various chemokines and cytokines are known to be capable of inducing longlasting increases in sensory nerve excitability and conductivity, eg, by modulation of Na V -and/or TRP-channel expression. 24, 58 However, such mechanisms would have to be relatively selective because, eg, HPTs and histaminergic itch did not differ significantly between groups, (2) prolonged afferent pruriceptive barrage causing centralized sensitization for mechanoreceptive signaling (as well as nonhistaminergic itch), (3) skin barrier alterations either associated with AD itself, scratching, or as a consequence of prolonged usage of topical corticosteroids. The additional sensitization observed intralesionally could mechanistically resemble the localized hyperalgesia repeatedly shown in HCs immediately after an itch provocation. 6, 52, 66, 78 Ikoma et al. also used noxious pinprick stimuli in patients with AD and found increased itch responses inside and immediately outside of lesions. However, in that study, the difference only manifested in increased ratings of itch (akin to what we observed in response to von Frey filaments during the dedicated hyperknesis assessments), whereas no differences were observed for pain. This discrepancy is likely related to the much higher maximal stimulus intensities used in the present study.
Increased sensitivity to chemical itch provocations
In the present study, very similar itch responses were observed after histamine provocation between nonlesional AD and HC skin. This is in line with most previous studies conducting such itch provocations, although outlying studies do exist wherein both increased and decreased sensitivity have been described. 5, 38, [41] [42] [43] 48, 67, 91 In lesional AD skin, previous studies have found either no or moderate increases in histamine itch responses, 5, 38, 41, 42, 76 in line with the trend observed in the present study. Hence, although histamine signaling appears to be slightly sensitized in the lesional skin, it is unaltered or even decreased in nonlesional www.painjournalonline.comskin. The intralesional sensitization to histamine (insignificant when multiplicity corrected) coincided with mild heat hyperalgesia when a paired analysis was conducted in the AD group. Mechanistically, this suggests that in AD skin, modestly sensitized TRPV1-signaling associated with the histaminergic CMi-fiber pathway of itch could contribute to augmented itch in response to histamine. This could perhaps also explain the intralesional heat-pain evoked itch observed in a previous study in patients with AD. 40 In contrast to histamine provocations, cowhage provocations have not previously been conducted in lesional AD skin. Presently, we show that patients display increased sensitivity to cowhageinduced itch not only when applied intralesionally, but also in extralesional skin. The prominent itch responses to nonhistaminergic chemical pruritic stimulation suggest that pathway-specific itch sensitization may be implicated in the sensory symptomatology of AD. Conflicting evidence exists regarding sensitivity to cowhageinduced itch in nonlesional AD skin. Papoiu et al. 67 found no differences between HCs and patients with AD, but the sample size was modest and the evoked itch was unusually strong in both AD and HCs, so a ceiling effect could have been present. Oppositely, a recent paper with a larger sample size found increased itch in response to cowhage in patients with AD akin to the results of the present study and suggested that cowhage (and histamine) provocations might have a diagnostic value for AD. 34 Lastly, a study injecting the chemical PAR2-agonist SLIGKV found increased itch responses in patients with AD compared with HCs. 83 The presence of intralesional and extralesional hypersensitivity to cowhageinduced, nonhistaminergic itch suggests that new pharmaceuticals targeting PAR2 and, importantly, its downstream mediator TRPA1, could be effective antipruritics in AD. Several such drug candidates are currently under development. 14, 95 The findings also lend mechanistic support to the notion that antihistamines are ineffective as antipruritics in AD. 27, 68, 90 The cause of the blunted flare reactions in nonlesional skin of patients with AD after histamine provocations is unknown but the phenomenon has previously been reported 34, 41 and could account for the slow decline in histaminergic itch observed in patients with AD in several studies by hampering local tissue clearance of introduced histamine. 7, 34, 41 The present evidence cannot be applied to interpret the relative peripheral vs central contribution to the observed neuronal sensitization. However, it is most feasible that the sensitization found to both chemical and mechanical stimuli in otherwise asymptomatic skin is driven by central mechanisms, while the "additional" sensitization observed within lesions is likely initiated by peripheral mechanisms associated with ongoing inflammation, itch, and pain. However, the increased responses to intralesional tests could also be related to a stronger localized segmental sensitization (perhaps particularly pertinent for hyperknesis) still mediated on a spinal level.
Hyperknesis to von Frey stimuli in AD
Mechanical pinprick hyperalgesia is pronounced in certain pain populations, 56, 57 and thus it is pertinent to study the parallel phenomenon, hyperknesis, in relation to itch. When stimulating with von Frey filaments in a preoptimized force range 7 before itch provocations, significantly higher itch ratings were found in the AD group intralesionally and extralesionally (Fig. 4) . This is aligned with a previous study in patients with AD using custom-made weighted needles to conduct a similar assessment 40 and case reports in patients with neuropathic itch. 12 This mechanically evoked itch hypersensitivity was aggravated after subsequent itch provocations, most prominently in lesional skin, but also in non-lesional skin, where cowhage elicited significantly stronger hyperknesis in patients with AD compared with the HC group. It is unclear which neuronal structures convey mechanically evoked itch. Selective tactile Cfibers have been proposed, 30 but Ad-and PmC-fibers seem to be more probable candidates: the Ad-nociceptors because of their involvement in pinprick hyperalgesia 100 and the PmC-fibers because of the delayed onset of itch after mechanical stimuli. 40 It is likely that increased responsiveness to mechanical itch stimuli involves a Cfiber-initiated sensitization of central pruriceptive neurons, which then in turn receive convergent input from relevant mechanosensitive units, thus mediating an augmented sense of mechanically evoked itch akin to the mechanism involved in pinprick hyperalgesia. 49, 81 Assessment of mechanical pain hypersensitivity has been widely used in clinical pain research as a tool to assess potential sensitization, and recent studies indicate that it could be a valuable guide and predictor of therapeutic responsiveness to analgesic drugs and other interventions. 16, 26, 56, 57, 72 The clinical use of assessment of hyperknesis and alloknesis as well as itch sensitization in general (eg, sensitization to chemical provocations) remains to be explored. Clearly, antipruritic therapeutic measures should focus on reducing local inflammation and targeting the underlying cause. However, tentatively, patients with AD displaying no signs of sensitization might respond favorably to peripherally acting antiinflammatory and immunemodulatory drugs, whereas patients exhibiting significant itch sensitization may benefit more from antipruritic therapy that also inhibits central processing of itch.
Because pruriceptive afferents generally also respond to certain nociceptive stimuli (evoking pain) and as such are nociceptors, the hypothesis has been proposed that neuronal encoding of itch may rely on a high spatial contrast from afferent input. That is, if a few cutaneous nociceptors are activated while neighboring units remain silent, itch is perceived, whereas more uniform nociceptive activation causes pain perception 51, 60, 61, 78 (the spinal or supra-spinal filtering mechanism for such encoding is unknown). The combined findings of intralesional decreased tactile sensitivity increased MPS, increased itch in response to cowhage, and von Frey stimuli could perhaps be interpreted in the light of this hypothesis. That is, increased MDT suggests fiber denervation (aligned with studies showing decreased intraepidermal density in AD skin 70 ); this could facilitate increased spatial contrast to the cowhage provocations and von Frey itch probing. Because increased MPS was also observed, these findings could collectively be interpreted as a combination of activation of fewer nociceptive endings concurrently with stronger activation of the remaining endings because of sensitization.
Conclusion
In summary, patients with AD display aberrant somatosensory sensitivity to distinct chemical and mechanical stimuli. This enhanced sensitivity is not restricted to the lesional skin areas and thus presumably involves both centrally and peripherally mediated sensitization mechanisms. Investigated for the first time, marked intralesional as well as extralesional hypersensitivity to cowhage-induced nonhistaminergic itch was shown. Moreover, increased sensitivity to pain-and itch-evoking mechanical stimuli, but not to histamine-induced itch, was found. This suggests that PAR2-positive PmC-nociceptors are involved in chronic itch signaling and itch sensitization in AD and highlights this pathway as a potential future therapeutic target.
